Latest 8-K filings

Eagle Point Credit Company provides an unaudited estimate of its net asset value per common share as of September 30, 2026, and net investment income for the quarter ended September 30, 2026.

Data443 Risk Mitigation, Inc. announces the general availability of Vaikora, an AI runtime enforcement and control platform designed to manage AI agent actions and data flows.

Vir Biotechnology and Gilead Sciences have entered a multi-program collaboration to discover and develop novel T-cell engagers for solid tumors, with Gilead investing $25 million in Vir Bio stock.

Datacentrex, Inc. has begun energizing over 500 new ElphaPex DG2 Scrypt ASIC miners, expected to increase its online hashrate by approximately 21% to 52.2 TH/s.

Eagle Point Income Company provided unaudited estimates for net asset value per common share and net investment income for the quarter ended September 30, 2026.

Coya Therapeutics announced the initiation of an open-label extension for its Phase 2/3 ALSTARS trial in ALS and a revised timeline for its FTD trial.

Valion Bio highlights its subsidiary Velocity Bioworks' capabilities to support domestic biologics manufacturing amid new tariffs, positioning it as a strategic asset for early-phase development.

Flex Ltd. announced the completion of its acquisition of EPC Power for $4.4 billion, funded by a combination of new credit facilities and cash, alongside plans to spin off its Cloud and Power Infrastructure segment into Axiom Solutions International.

MaxCyte, Inc. announced preliminary Q3 2026 revenue of approximately $8.1 million, a 26% increase year-over-year, and raised its full-year 2026 revenue guidance to $34 million.

Sabre Corporation's subsidiary, Sabre Financial Borrower, LLC, has successfully settled its tender offer for 11.125% Senior Secured Notes due 2029 and redeemed the remaining principal.

Profound Medical Corp. announced new data from five abstracts presented at the 15th Interventional MRI Symposium, reinforcing the real-world performance and clinical differentiation of its TULSA-PRO system.

WhiteHorse Finance, Inc. announced a special distribution of $0.17 per share and set November 9, 2026, as the release date for its third quarter financial results.

OneMedNet Corporation announced it has regained compliance with Nasdaq's minimum bid price requirement, closing a matter that previously threatened its listing.

Fermi Inc. announced a significant 15-year lease agreement with AI cloud provider TensorWave for 222 MW of power capacity, backed by AMD's credit support.

Strive, Inc. announced the exercise of over 273 million warrants, generating approximately $369.2 million in gross proceeds, and a significant purchase of 2,822 Bitcoin.

Akebia Therapeutics announces the resignation of its Senior Vice President and Chief Commercial Officer, Nicholas Grund, effective November 6, 2026, with a subsequent consulting agreement until April 30, 2027.

Fastenal Company announced robust third quarter 2026 results, highlighted by a 15.5% increase in daily sales, a 90 basis point improvement in operating margin, and strong operating cash flow.

Entrada Therapeutics announced positive topline results from the first cohort of its Phase 1/2 ELEVATE-45-201 study for ENTR-601-45, demonstrating favorable safety, tolerability, and increased dystrophin production in Duchenne Muscular Dystrophy patients.

Cipher Digital Inc. announced the pricing of an $850 million offering of 0.00% convertible senior notes due 2032 and a concurrent exchange of its 2030 notes, aiming to fund growth initiatives.

Brightline Interactive announced it has regained compliance with Nasdaq's minimum bid price rule following a 1-for-8 reverse stock split.

Morgan Stanley announced robust third quarter 2026 results, with net revenues reaching $20.3 billion and diluted earnings per share at $3.03.

Faraday Future Intelligent Electric Inc. has entered into a definitive agreement to sell its robotics business to FF EAI Robotics Inc. for approximately $200 million in an all-stock transaction.

FF EAI Robotics Ecosystem Inc. has signed definitive agreements to acquire Faraday Future Intelligent Electric Inc.'s robotics business for approximately $200 million in an all-stock transaction, aiming to become a leading U.S.-listed robotics company.

State Street Corporation announced robust third-quarter 2026 results, showcasing record AUC/A and AUM, significant revenue growth, and progress on strategic initiatives.

Karyopharm Therapeutics Inc. has extended its debt forbearance period for the second time, pushing the deadline to October 22, 2026, indicating continued financial negotiations.

Aquestive Therapeutics grants Eton Pharmaceuticals exclusive U.S. rights for LIBERVANT (diazepam) buccal film, securing upfront fees and potential milestone and royalty payments.

Eton Pharmaceuticals and Aquestive Therapeutics have inked an exclusive U.S. licensing deal for LIBERVANT (diazepam) buccal film, a novel treatment for seizure clusters, targeting a market exceeding $450 million.

Sono-Tek Corporation announced fiscal second quarter and first half FY27 results, highlighting a 289% surge in medical market sales and expanded gross margins, while reiterating full-year revenue guidance.

Xeris Biopharma Holdings, Inc. has filed patent infringement lawsuits against multiple defendants concerning its KEVEYIS (dichlorphenamide) product.

Entegris, Inc. announced its board of directors has declared a quarterly cash dividend of $0.10 per share, payable on November 18, 2026.